We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.22B
AUM Growth
+$77.6M
Cap. Flow
+$59.9M
Cap. Flow %
4.93%
Top 10 Hldgs %
46.33%
Holding
332
New
35
Increased
189
Reduced
69
Closed
18

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.41%
2 Technology 7.75%
3 Healthcare 2.78%
4 Financials 1.79%
5 Communication Services 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPEM icon
326
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.8B
-6,000
Closed -$217K
STLA icon
327
Stellantis
STLA
$20.4B
-12,162
Closed -$344K
STM icon
328
STMicroelectronics
STM
$44B
-5,337
Closed -$231K
TAK icon
329
Takeda Pharmaceutical
TAK
$57.6B
-25,461
Closed -$354K
TRV icon
330
Travelers Companies
TRV
$77.2B
-944
Closed -$217K
VUG icon
331
Vanguard Morningstar Growth ETF
VUG
$228B
-5,100
Closed -$293K
PXD
332
DELISTED
Pioneer Natural Resource Co.
PXD
-778
Closed -$204K

Similar funds

Callan Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Callan Capital held 332 positions worth $1.22B, up 6.8% from $1.14B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Callan Capital deployed $59.9M of net new capital in Q2 2024, opening 35 new positions and adding to 189 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.96M trimmed.

  • Callan Capital's largest Q2 2024 buy was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
  • Callan Capital added most to NVIDIA in Q2 2024, an estimated $18.4M increase.
  • Callan Capital's biggest Q2 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.96M.
  • Callan Capital fully exited Takeda Pharmaceutical in Q2 2024, selling an estimated $354K.
  • Callan Capital's ten largest holdings make up 46% of its $1.22B portfolio in Q2 2024.
  • Callan Capital opened 35 new positions and closed 18 in Q2 2024.
  • Callan Capital's portfolio value rose 6.8% quarter-over-quarter to $1.22B.

Based on Callan Capital's 13F filing for Q2 2024, filed 12 Aug 2024.